论文标题
认知下降中的定量敏感性映射:技术方面和应用的综述
Quantitative Susceptibility Mapping in Cognitive Decline: A Review of Technical Aspects and Applications
论文作者
论文摘要
在人脑中,转铁蛋白(TF)和铁蛋白(FE3)形式存在用于适当神经功能的必需铁分子。但是,其异常的增量表现出铁超载,这与过氧化氢反应。该反应将产生羟基自由基,并产生更高的氧化状态。此外,该反应会导致组织损伤或大脑认知下降,并导致神经退行性疾病。铁超负荷导致的易感性差异(VOI)负责MRI的现场扰动,并且可以在估计神经疾病中受益。定量敏感性映射(QSM)技术可以估计敏感性的改变,并有助于量化局部组织易感性差异。它吸引了许多研究人员和临床医生来诊断和检测帕金森氏症,阿尔茨海默氏症,多发性硬化症和衰老等神经疾病。本文提出了一项系统的综述,说明了QSM基础知识及其处理步骤,包括阶段解开,背景场外删除和敏感性反转。使用QSM,目前的工作为各种神经疾病提供了新颖的预测生物标志物。它可以增强新的研究人员的基本知识,并洞悉其在认知下降披露中的适用性。本文讨论了QSM处理阶段的未来范围及其在识别新生物标志物的神经疾病中的应用。
In the human brain, essential iron molecules for proper neurological functioning exist in transferrin (tf) and ferritin (Fe3) forms. However, its unusual increment manifests iron overload, which reacts with hydrogen peroxide. This reaction will generate hydroxyl radicals, and irons higher oxidation states. Further, this reaction causes tissue damage or cognitive decline in the brain and also leads to neurodegenerative diseases. The susceptibility difference due to iron overload within the volume of interest (VOI) responsible for field perturbation of MRI and can benefit in estimating the neural disorder. The quantitative susceptibility mapping (QSM) technique can estimate susceptibility alteration and assist in quantifying the local tissue susceptibility differences. It has attracted many researchers and clinicians to diagnose and detect neural disorders such as Parkinsons, Alzheimers, Multiple Sclerosis, and aging. The paper presents a systematic review illustrating QSM fundamentals and its processing steps, including phase unwrapping, background field removal, and susceptibility inversion. Using QSM, the present work delivers novel predictive biomarkers for various neural disorders. It can strengthen new researchers fundamental knowledge and provides insight into its applicability for cognitive decline disclosure. The paper discusses the future scope of QSM processing stages and their applications in identifying new biomarkers for neural disorders.